Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support

Objectives: To develop a population pharmacokinetic model of meropenem in children with sepsis receiving extracorporeal life support (ECLS) and optimize the dosage regimen based on investigating the probability of target attainment (PTA).Methods: The children with sepsis were prospectively enrolled...

Full description

Bibliographic Details
Main Authors: Yixue Wang, Weiming Chen, Yidie Huang, Guangfei Wang, Zhiping Li, Gangfeng Yan, Chao Chen, Guoping Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.699191/full
id doaj-11ef7526a5cd462099876df91e2545e7
record_format Article
spelling doaj-11ef7526a5cd462099876df91e2545e72021-08-24T10:08:39ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-08-011210.3389/fphar.2021.699191699191Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life SupportYixue Wang0Weiming Chen1Yidie Huang2Guangfei Wang3Zhiping Li4Gangfeng Yan5Chao Chen6Guoping Lu7Department of Pediatric Critical Care Medicine, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Pediatric Critical Care Medicine, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Clinical Pharmacy, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Clinical Pharmacy, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Clinical Pharmacy, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Pediatric Critical Care Medicine, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Neonatology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaDepartment of Pediatric Critical Care Medicine, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, ChinaObjectives: To develop a population pharmacokinetic model of meropenem in children with sepsis receiving extracorporeal life support (ECLS) and optimize the dosage regimen based on investigating the probability of target attainment (PTA).Methods: The children with sepsis were prospectively enrolled in a pediatric intensive care unit from January 2018 to December 2019. The concentration-time data were fitted using nonlinear mixed effect model approach by NONMEM program. The stochastic simulation considering various scenarios based on proposed population pharmacokinetics model were conducted, and the PTAs were calculated to optimize the dosage regimens.Results: A total of 25 children with sepsis were enrolled, of whom13 received ECMO, 9 received CRRT, and 4 received ECMO combined with CRRT. 12 children received a two-step 3-h infusion and 13 children received 1-h infusion. Bodyweight and creatinine clearance had significant impacts on the PK parameters. ECMO intervention was not related to the PK properties. If 100%T > MIC was chosen as target, children receiving 40 mg/kg q8h over a 3 h-infusion only reached the PTA up to 77.4%. If bacteria with MIC 2 mg/L were to be treated with meropenem and the PTA target was 50%T > MIC, a dose of 40 mg/kg q8h for 1 h infusion would be necessary.Conclusions: The PK properties of meropenem in septic children receiving extracorporeal life support were best described. We recommended the opitimized dosing regimens for septic children receiving ECLS depending on the PTA of PK target 50%T > MIC and 100%T > MIC, for children with sepsis during ECLS with different body weight, estimated creatinine clearance (eCRCL) and MIC of bacteria.https://www.frontiersin.org/articles/10.3389/fphar.2021.699191/fullmeropenempharmacokinetics/pharmacodynamicschildrensepsiseven extracorporeal membrane oxygenationcontinuous renal replacement therapy
collection DOAJ
language English
format Article
sources DOAJ
author Yixue Wang
Weiming Chen
Yidie Huang
Guangfei Wang
Zhiping Li
Gangfeng Yan
Chao Chen
Guoping Lu
spellingShingle Yixue Wang
Weiming Chen
Yidie Huang
Guangfei Wang
Zhiping Li
Gangfeng Yan
Chao Chen
Guoping Lu
Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
Frontiers in Pharmacology
meropenem
pharmacokinetics/pharmacodynamics
children
sepsis
even extracorporeal membrane oxygenation
continuous renal replacement therapy
author_facet Yixue Wang
Weiming Chen
Yidie Huang
Guangfei Wang
Zhiping Li
Gangfeng Yan
Chao Chen
Guoping Lu
author_sort Yixue Wang
title Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
title_short Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
title_full Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
title_fullStr Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
title_full_unstemmed Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
title_sort optimized dosing regimens of meropenem in septic children receiving extracorporeal life support
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2021-08-01
description Objectives: To develop a population pharmacokinetic model of meropenem in children with sepsis receiving extracorporeal life support (ECLS) and optimize the dosage regimen based on investigating the probability of target attainment (PTA).Methods: The children with sepsis were prospectively enrolled in a pediatric intensive care unit from January 2018 to December 2019. The concentration-time data were fitted using nonlinear mixed effect model approach by NONMEM program. The stochastic simulation considering various scenarios based on proposed population pharmacokinetics model were conducted, and the PTAs were calculated to optimize the dosage regimens.Results: A total of 25 children with sepsis were enrolled, of whom13 received ECMO, 9 received CRRT, and 4 received ECMO combined with CRRT. 12 children received a two-step 3-h infusion and 13 children received 1-h infusion. Bodyweight and creatinine clearance had significant impacts on the PK parameters. ECMO intervention was not related to the PK properties. If 100%T > MIC was chosen as target, children receiving 40 mg/kg q8h over a 3 h-infusion only reached the PTA up to 77.4%. If bacteria with MIC 2 mg/L were to be treated with meropenem and the PTA target was 50%T > MIC, a dose of 40 mg/kg q8h for 1 h infusion would be necessary.Conclusions: The PK properties of meropenem in septic children receiving extracorporeal life support were best described. We recommended the opitimized dosing regimens for septic children receiving ECLS depending on the PTA of PK target 50%T > MIC and 100%T > MIC, for children with sepsis during ECLS with different body weight, estimated creatinine clearance (eCRCL) and MIC of bacteria.
topic meropenem
pharmacokinetics/pharmacodynamics
children
sepsis
even extracorporeal membrane oxygenation
continuous renal replacement therapy
url https://www.frontiersin.org/articles/10.3389/fphar.2021.699191/full
work_keys_str_mv AT yixuewang optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport
AT weimingchen optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport
AT yidiehuang optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport
AT guangfeiwang optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport
AT zhipingli optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport
AT gangfengyan optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport
AT chaochen optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport
AT guopinglu optimizeddosingregimensofmeropeneminsepticchildrenreceivingextracorporeallifesupport
_version_ 1721197665074544640